Pan-cancer analysis of SOX2: Prognostic implications and potential as a therapeutic target in immune checkpoint modulation
This study investigates SOX2 genetic, transcriptomic, and epigenetic alterations across over 30 cancer types. Significant downregulation of SOX2 expression was observed in colorectal adenocarcinoma, esophageal carcinoma, rectum adenocarcinoma, stomach adenocarcinoma, and testicular germ cell tumors,...
Saved in:
Main Authors: | Shoukai Yu, Lingmei Qian, Liling Xu, Jun Ma |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844025005808 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SOX-9 as a prognostic marker in gastric adenocarcinoma
by: Efe Yetişgin, et al.
Published: (2025-01-01) -
Therapeutic potential of SOX family transcription factors in osteoarthritis
by: Yue Huang, et al.
Published: (2025-12-01) -
Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of PDGFB
by: Bai Y, et al.
Published: (2025-01-01) -
Elevated SREBP1 accelerates the initiation and growth of pancreatic cancer by targeting SOX9
by: Cancan Zhou, et al.
Published: (2025-01-01) -
Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy
by: Levent PAY, et al.
Published: (2024-12-01)